For GLP-1 users Follow the dose escalation schedule
Exchange Act, Dhler or its nominees, or its brokers (acting as agents), may from time to time make certain purchases of or arrangements to purchase, shares or other securities of Treatt outside of the U.S., other than pursuant to the takeover offer, until the date on which the takeover offer becomes effective, lapses or is otherwise withdrawn
He wants to maintain a solid shape even if the weight goes up
Patients should experience minimal or no gastrointestinal symptoms at their current dose, with resolution of initial nausea, vomiting, or diarrhea
Future research should aim to identify patient subgroups most likely to benefit